Titlebook: Ubiquitin-Proteasome Protocols; Cam Patterson,Douglas M. Cyr Book 2005 Humana Press 2005 Endoplasmatisches Reticulum.Termination.biochemis

只看該作者 · 發(fā)表于 2025-3-23 22:47:00

Purification of E1 and E1-Like Enzymesman red blood cells in yields (2–4 nmol/U of blood) that make this an attractive alternative to expression of the proteolytically labile recombinant protein. In addition, two stoichiometric activity assays are described that rely on formation of the E1 .I-ubiquitin thiol ester and ubiquitin [2,8-.H]adenylate intermediates.

只看該作者 · 發(fā)表于 2025-3-24 04:13:41

只看該作者 · 發(fā)表于 2025-3-24 06:37:21

只看該作者 · 發(fā)表于 2025-3-24 13:31:56

只看該作者 · 發(fā)表于 2025-3-24 15:38:32

Shahri Raasi,Cecile M. Pickarto effective prevention. This has always been one of our worst kept secrets. Equally conflicts of interest [.] assume particular relevance in an occupation whose foundation values demand a robust ethical identity. This is the topic of this essay.

只看該作者 · 發(fā)表于 2025-3-24 20:24:16

只看該作者 · 發(fā)表于 2025-3-24 23:24:42

Small-Molecule Inhibitors of Proteasome Activityl-molecule compounds blocking its activities. Besides being candidates for drugs against cancer, autoimmune diseases, inflammation, or stroke, specific proteasome inhibitors are indispensable tools for biochemical and cell biology investigations of the proteasome and proteasome-ubiquitin system. Num

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 21:23
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved